Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix® and FOLFIRI or FOLFOX in First Line (VALIDATE)
Clinical trial NCT03043950 · COMPLETED
Trial details
- NCT number
- NCT03043950
- Sponsor
- iOMEDICO AG
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-01-25
- Primary completion
- 2024-01-17
- Enrollment
- 647
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.